Trigg Minerals
Investor Insight With strategic, US-based assets, Trigg Minerals is well-positioned to become a cornerstone supplier of antimony and tungsten into the United States and allied markets. With a sharpened focus…
Investor Insight With strategic, US-based assets, Trigg Minerals is well-positioned to become a cornerstone supplier of antimony and tungsten into the United States and allied markets. With a sharpened focus…
Peter Schiff, chief economist and global strategist at Euro Pacific Asset Management and founder of Schiff Gold, shares his outlook on gold and silver prices. He also discusses Bitcoin and…
Chris Marcus, founder of Arcadia Economics, shares his thoughts on silver and gold. While it’s impossible to know exactly how precious metals prices will move in the short term, he’s…
Regardless of how the gold price is doing, the top gold-mining companies are always making moves. Right now, gold is in the limelight — stimulated by increasing global inflation, geopolitical…
Discovery of uranium mineralization in ideal geological setting, supported by regional radiometric anomaly, confirms large Rossing-style target ReeXploration Inc. (TSXV: REE) (FSE: K2I0) (‘ReeXploration’ or the ‘Company’) is pleased to…
Osisko Metals Incorporated (the ‘ Company or ‘ Osisko Metals ‘) ( TSX: OM,OTC:OMZNF ; OTCQX: OMZNF ; FRANKFURT: 0B51 ) is pleased to announce new drill results from the…
Development-ready gold asset in premier mining jurisdiction with funded advancement plan; preparing to initiate project-development and exploration drill program Fortune Bay Corp. (TSXV: FOR,OTC:FTBYF) (FWB: 5QN) (OTCQB: FTBYF) (‘Fortune Bay’…
Mark Skousen of Forecasts & Strategies shares his outlook for gold, silver and the US economy. ‘We’ve entered an era of what I call permanent inflation,’ he explained. ‘After World…
Questcorp Mining Inc. (CSE: QQQ,OTC:QQCMF) (OTCQB: QQCMF) (FSE: D910) (the ‘Company’ or ‘Questcorp’) is pleased to announce that Sorbie Bornholm LP (‘Sorbie’), a UK Investment Fund, has undertaken an initial…
InMed Pharmaceuticals (NASDAQ: INM) pairs innovative therapeutic development in Alzheimer’s, ophthalmology, and dermatology with recurring revenue from its BayMedica manufacturing division — giving investors rare small-cap biotech exposure to high-impact…